Navigation Links
Lawson researchers engineer a switch to tame aggressive cancers
Date:1/19/2012

LONDON, ON When cancers become aggressive and spread they are the most deadly. Unfortunately, little is known about how to stop this development. A new imaging platform developed by Lawson Health Research Institute's Drs. Ann Chambers and John Lewis is providing insight into just that - the exact moment when cancer cells turn deadly.

Certain proteins, such as E-cadherin, are important for the maintenance of normal tissue structure. When tumors become more aggressive, they often lose E-cadherin, resulting in dramatic changes to their structure, function and ability to spread. But when cancer cells are forced to express E-cadherin, research suggests they behave less aggressively and revert back to normal. Unfortunately, limitations in our ability to directly monitor these effects have made it difficult for scientists to assess the full impact.

In a study released today in PLoS ONE, Drs. Chambers and Lewis reveal a new imaging platform that can modulate and monitor how the effects of a particular protein can affect the entire tumor in real-time. The approach uses a shell-less chick embryo model implanted with human cancer cells. "This accessible set-up allows us to introduce E-cadherin directly into the tumor environment, where it has immediate and dramatic effects," says Dr. Hon Leong, the lead author of this study. "Using 3D time-lapse imaging, the impact of this protein can be visualized and the subsequent effects on cancer cell structure, function and aggressiveness can be monitored in real time for up to 48 hours."

Drs. Chambers and Lewis hope this approach will allow scientists to determine how proteins like E-cadherin can exert their tumor-suppressive properties on the deadly spread of cancer. Through further research, they believe their approach could provide valuable information to help moderate aggressive cancers and improve patient outcomes.

"The insights afforded by this technology will help scientists revisit other proteins thought to be important in metastatic spread, but whose modes of action are not understood, and to watch how they actually function in real-time," says Dr. Chambers.

"Although genomics technology has revealed many new proteins that could force cancers to 'switch' back to their less aggressive state, these new targets have not yet been validated in preclinical models like mice because it is difficult to determine the molecular effects on each individual cancer cell," Dr. Lewis says. "This novel platform allows us to produce compelling photographic evidence of how these anti-cancer proteins work and gain insight into their mechanisms."


'/>"/>
Contact: Sonya Gilpin
sonya.gilpin@lawsonresearch.com
519-685-8500 x75852
Lawson Health Research Institute
Source:Eurekalert

Related medicine news :

1. Lawson proves real people drive research
2. Lawson scientist presents joint pain treatment 2.0
3. UC Davis researchers refine nanoparticles for more accurate delivery of cancer drugs
4. Researchers study how chemicals in drugs and around us impact stem cells
5. University of Granada researchers identify changes in tumor cells that lead to metastasis
6. Cell death researchers identify new Achilles heel in acute myeloid leukemia
7. How immune cells destroy cancer cells - MDC researchers elucidate mechanism
8. UBC researchers identify potential new therapy approach for hepatitis C
9. Mass. General researchers find novel way to prevent drug-induced liver injury
10. Researchers use sugar to halt esophageal cancer in its tracks
11. Little Known About How Autism Affects Teen Drivers: Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , ... February 22, 2017 , ... ... and the number of African American/Black students who want to become physicians. PMF ... pursue their careers as physicians in the Oakland/San Francisco Northern California, Bay Area. ...
(Date:2/21/2017)... ... February 21, 2017 , ... Hanna Boys Center ... will be the keynote speaker at its second Professional Networking Breakfast on March ... which develops comprehensive strategies to create and expand opportunities for boys and young ...
(Date:2/21/2017)... ... February 21, 2017 , ... Ray Insurance Agencies, a Dallas area ... Tarrant County, is embarking on a six month charity event aimed at raising local ... , Cancer is one of the deadliest diseases in America; more than 7.5 million ...
(Date:2/21/2017)... Michigan (PRWEB) , ... February 21, 2017 , ... ... to the United States during Black History Month (officially African American History ... to many fields of American society of a diverse race of people, but ...
(Date:2/21/2017)... CA (PRWEB) , ... February 21, 2017 , ... A ... data on gastric balloons for weight loss. It found that the treatments have led ... of obese patients, when compared to unassisted efforts. It also noted very few problematic ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017 Henry ... an exclusive distribution agreement with Rijuven, which develops ... diagnostic device to medical practitioners. ... electrocardiogram (ECG) and heart sound signals, transmits real-time ... and offers cloud-based analysis to help physicians provide ...
(Date:2/22/2017)... -- Bioness, Inc., the leading provider of cutting edge, clinically ... successful StimRouter Neuromodulation System implantations in Europe ... Netherlands ), South Victoria ... Kliniek Park Leopold Chirec ( Brussels, Belgium ... further support clinicians across the continent who are looking ...
(Date:2/22/2017)... , Feb. 22, 2017 Oncternal Therapeutics, ... for both rare and common malignancies, today announced ... financing. The company intends to use the proceeds ... TK216, and to advance preclinical development of a ... Cirmtuzumab is a first-in-class anti-ROR1 monoclonal antibody being ...
Breaking Medicine Technology: